About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Developing CAR T-cells in Multiple Myeloma
By
Krina Patel
10 Videos
April 30, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:52
Lilly
BTK Inhibition for Patients with MCL: Safety and Efficacy Data
Feat.
J. Pagel
Featured Video
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
Related Content
AUTOPLAY
ON
5th SOHO Italy Annual Conference
5th SOHO Italy Annual Conference
Tue, Oct 3, 2023
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights State of the Art and Next Questions
Wed, Nov 1, 2023
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
07:11
GRACE
CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…
Feat.
A. Goodman,
A. Jeong,
S. Rajeeve
14:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…
Feat.
H. Hashmi
04:08
GRACE
CAR T-Cell Therapy Side Effects for Blood Cancers
Feat.
A. Goodman
18:26
William Schaffner
Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
12:33
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…
Feat.
K. Patel
05:56
ASH 2022 Conference Coverage
ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalido…
Feat.
G. Morgan
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
05:22
PrecisCa
Teclistamab in R/R Multiple Myeloma: Results From the MajesTEC-1 Tri…
Feat.
A. Nooka
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
52:39
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
Feat.
A. Chari
15:08
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
New Therapies for Relapsed Myeloma in 2023
Feat.
D. Vogl
30:59
Houston Methodist Hospital
Overview of Advances in Multiple Myeloma
Feat.
S. Ganguly
06:11
Insights from 2023 EHA® Annual Meeting
EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-U…
Feat.
A. Varshavsky-Yanovsky
15:54
Paul Richardson
Emerging Strategies in the Management of Relapsed MM
11:20
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - …
Feat.
B. Dhakal
18:27
Indy Hematology Review
DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…
Feat.
J. Mikhael
